| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Pharmacogenomics| 1 | 2005 | Pharmacogenetics in drug regulation: promise, potential and pitfalls. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 360(1460):1617-38 (2005) Shah RR |
| 2 | 2008 | Pharmacogenomics: candidate gene identification, functional validation and mechanisms. |
| + | - | nl | Hum Mol Genet 17(R2):R174-9 (2008) |
| 3 | 2006 | Pharmacogenomics: from bedside to clinical practice. |
| + | - | nl | Hum Mol Genet 15 Spec No 1(-):R89-93 (2006) |
| 4 | 2011 | Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others. |
| + | - | nl | Cleve Clin J Med 78(4):243-57 (2011) Kitzmiller JP |
| 5 | 2010 | The role of genomic oxidative-reductive balance as predictor of complex regional pain syndrome development: a novel theory. |
| + | - | nl | Pain Physician 13(1):79-90 (2010) |
| 6 | 2011 | Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs. |
| + | - | nl | Pharmacol Rep 63(2):293-304 (2011) |
| 7 | 2010 | Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. | 
| + | - | nl | Clin Exp Immunol 159(3):268-80 (2010) |
